Abstract
The present invention is a method for using crosslinked amniotic membrane, which utilizes EDC to crosslink thereby, as biomedical material. Disclosed is more resistant to protease, and furthermore, crosslinks specific extracellular matrix, such as heparin, by the functional group for crosslink. In addition, utilizing the affinity between these extracellular matrix and specific growth factors, amniotic membrane turns into carriers overexpressing some kind of growth factors for treating specific disease.
Translated title of the contribution | Method for using crosslinked amniotic membrane as biomedical material |
---|---|
Original language | Chinese (Traditional) |
IPC | A61K 35/50(2015.01); A61L 31/12(2006.01); A61P 31/00(2006.01); A61F 9/02(2006.01) |
State | Published - 16 04 2007 |
Bibliographical note
公開公告號: 2.00714286E8Announcement ID: 2.00714286E8